Rejoining of broken chromosomes is crucial for cell survival and prevention of malignant transformation. Most mammalian cells rely primarily on the non-homologous end-joining pathway of DNA double-strand break (DSB) repair to accomplish this task. This review focuses both on the core non-homologous end-joining machinery, which consists of DNA-dependent protein kinase and the ligase IV/XRCC4 complex, and on accessory factors that facilitate rejoining of a subset of the DSBs. We discuss how the ATM protein kinase and the Mre11/Rad50/Nbs1 complex might function in DSB repair and what role ionizing radiation-induced foci may play in this process.
DNA damage induces several responses, including DNA repair, cell cycle checkpoints and apoptosis (Zhou and Elledge, 2000; Bartek and Lukas, 2007) . This is collectively referred to as the DNA damage response (DDR). DNA double-strand breaks (DSBs) pose a particularly severe threat to genome stability, since lack of repair may cause loss of chromosome fragments during mitosis, whereas coupling of the wrong DNA ends is the basis for chromosomal translocations that can induce neoplastic transformation (Burma et al., 2006) . To prevent loss of genetic material during mitosis, cells halt their cell cycle at the G 2 /M boundary until the majority of DSBs is repaired. On the other hand, excessively damaged cells can be eliminated by activation of apoptotic pathways, thereby preventing survival of cells that might have lost proper growth regulation, for example by loss of heterozygosity of a tumor suppressor gene.
The most important factor for cell survival is repair of the DNA damage. DSBs can be repaired by two fundamentally different mechanisms (Helleday et al., 2007) . Homologous recombination uses the information on the sister chromatid or the homologous chromosome to align both DNA ends. In mammalian cells, this repair pathway is probably restricted to the S and G 2 phases of the cell cycle when a sister chromatid is present. Nonhomologous end-joining (NHEJ) does not require a homologous DNA template, although short patches of homologous nucleotides (microhomologies of one or a few base pairs) are frequently used to align the DNA ends. This review focuses on the mechanism of NHEJ and the implications of defects in this repair pathway.
Outline of the NHEJ pathway
The NHEJ reaction starts with binding of the Ku70/80 heterodimer to a DNA end (Figure 1 ) (Weterings and van Gent, 2004) . DNA end bound Ku70/80 then attracts the catalytic subunit of the DNA-dependent protein kinase (DNA-PK CS ) and activates its protein kinase activity (Smith and Jackson, 1999) . Although many different targets have been identified, the major function for this phosphorylation activity appears to be regulation of the NHEJ reaction by DNA-PK CS autophosphorylation (Chan et al., 2002; Ding et al., 2003; Weterings et al., 2003) . This reaction takes place after juxtaposition of DNA ends and is required for proper regulation of DNA end accessibility for other NHEJ proteins (Meek et al., 2007) . Compatible DNA ends can now be joined directly by the ligase IV/XRCC4 complex. This reaction is stimulated by the recently discovered XLF/Cernunnos protein, which interacts with XRCC4 (Ahnesorg et al., 2006; Buck et al., 2006) . However, in many circumstances the DNA ends are not compatible. Ionizing radiation, for example, creates a large number of ends that contain damaged bases and/or DNA backbone sugars that need processing before ligation. Therefore, NHEJ can accommodate nucleases, DNA polymerases polynucleotide kinase and other enzymes that render such ends ligatable by the ligase IV/XRCC4 complex.
NHEJ is not only important for repair of DSBs that result from exogenous and endogenous DNA damaging agent, but also for repair of DSBs generated during V(D)J recombination, which takes place during B-and T-cell differentiation to generate antigen specific receptors (Jung et al., 2006) . Variable (V), Diversity (D) and Joining (J) segments in Immunoglobulin (Ig) and T Cell Receptor (TCR) genes are joined to form the mature V(D)J exon in B and T cells, respectively (Schatz, 2004) . The RAG1 and RAG2 proteins create DSBs at the border between conserved Recombination Signal Sequences (RSSs) and the coding DNA segments, creating blunt DNA ends at the RSS and coding ends with a hairpin structure in which the top strand is covalently coupled to the bottom strand (McBlane et al., 1995; van Gent et al., 1996) . These DSBs require the NHEJ machinery for their repair.
DNA-PK
The structure of the Ku70/80 heterodimer directly shows why this protein binds specifically to DNA ends: its ring shape allows it to thread onto a double-stranded DNA molecule, but not to internal DNA positions (Walker et al., 2001) . As expected on the basis of this structure, the protein can slide along a DNA molecule to internal positions without the need for an energy source, such as ATP (de Vries et al., 1989; Ristic et al., 2003) . The ring shape is made of approximately the N-terminal 500 amino-acid residues of Ku70 and Ku80. The Ku70 C terminus shows homology to a number of proteins and is called the SAP domain (Aravind and Koonin, 2000) . This domain has been found to bind to DNA in some other proteins and may also have a function as an accessory DNA binding domain in the Ku heterodimer, although it is not in close proximity to DNA in the crystal structure. However, this domain is connected to the rest of the Ku70 polypeptide with a flexible linker arm, which could facilitate considerable movement. The Ku80 C-terminal domain has been found to influence interaction with DNA-PK CS (Gell and Jackson, 1999; Singleton et al., 1999; Falck et al., 2005) .
Interaction between Ku70/80 and DNA-PK CS requires a DNA end. The assembled DNA-PK complex then acquires the ability to phosphorylate a number of target proteins, but the functional relevance of most targets is not clear. However, DNA-PK CS autophosphorylation is clearly important for the NHEJ reaction (Chan et al., 2002; Ding et al., 2003; Weterings et al., 2003) . It is accomplished in trans, after formation of a synaptic complex that brings together the two sides of the DSB (Meek et al., 2007) . Several clusters of autophosphorylation sites have been mapped. A cluster of seven sites between residues 2609 and 2647 has a major influence on remodeling the DNA-PK complex to make the DNA ends accessible for ligation (Ding et al., 2003; Block et al., 2004; Reddy et al., 2004) . Conversely, phosphorylation in the region between residues 2023-2056 appears to be involved in reducing access of nuclease activities to the DNA ends Cui et al., 2005) , while phosphorylation of residue 3950 also influences the joining efficiency . These autophosphorylation sites have been mapped after in vitro phosphorylation reactions and it is not completely clear whether phosphorylation at these sites requires DNA-PK activity in vivo; Ataxia-Telangiectasia mutated protein kinase (ATM) may also participate in a subset of these events . However, the importance of autophosphorylation has clearly been shown by mutagenesis of the phosphorylation sites, as well as the kinase domain in the DNA-PK CS gene .
Juxtaposition of the correct DNA ends is an obligatory step in the NHEJ process. The Ku70/80 heterodimer is necessary for this process, but DNA-PK CS is also required to form a stable synaptic complex in which both ends are held together. Such end-to-end junctions have been observed by Scanning Force Microscopy and cryo electron microscopy (Yaneva et al., 1997; Spagnolo et al., 2006) . Biochemical experiments have shown that DNA-PK CS is indeed required for stable juxtaposition of DNA ends (DeFazio et al., 2002; Drouet et al., 2005) . However, DNA-PK CS is not absolutely required for all end-joining events, because blunt DNA ends are joined with relatively high efficiency in DNA-PK CS deficient cells (Lieber et al., 1988; van Heemst et al., 2004) and DSB repair after ionizing radiation is much more efficient in these cells than in Ku80 or XRCC4 deficient cells (Riballo et al., 2004) .
Although Ku70/80 binds DNA ends quite tightly, Ku70/80 as well as DNA-PK CS exchange from DSBs within a few minutes in living cells (Mari et al., 2006 ; Figure 1 Non-homologous end-joining model. After double-strand break formation, the Ku70/80 heterodimer binds to the DNA ends and attracts DNA-PK CS . This activates the DNA-PK kinase activity, which leads to autophosphorylation, which enables the subsequent processing and ligation steps. The small triangle symbolizes a DNA end that needs processing before ligation. Uematsu et al., 2007) . The dynamics of NHEJ complexes are influenced dramatically by DNA-PK autophosphorylation: a DNA-PK CS mutant protein without kinase activity or with mutations in the autophosphorylation sites exchanged much more slowly than the wild type protein. The dynamic nature of these complexes is somewhat unexpected: as repair of approximately 75% of the DSBs takes 1 h, most NHEJ complexes fall apart before repair has been completed. It is presently not clear how this affects the chance to create chromosomal aberrations, but it is to be expected that dissociation of NHEJ complexes will be a prerequisite for formation of deletions and translocations.
DNA ligase IV, XRCC4 and XLF/Cernunnos
The final step in the NHEJ pathway is ligation of DNA ends by the DNA ligase IV/XRCC4 complex. NHEJ efficiency is minimal in the absence of this complex and a defect in ligase IV or XRCC4 is even lethal in mice (Barnes et al., 1998; Frank et al., 1998; Gao et al., 1998b) . XRCC4 is absolutely required for ligase IV activity, probably because the ligase IV protein needs it for stability and correct targeting to DSBs (Grawunder et al., 1997; Bryans et al., 1999; Chen et al., 2000; Teo and Jackson, 2000; Hsu et al., 2002; Drouet et al., 2005; Costantini et al., 2007) . The three dimensional structure of the largest part of the XRCC4 protein has been determined (Junop et al., 2000) . The most remarkable feature is a long a-helical stalk that gives the protein an extended structure, which would be ideal to serve as a flexible linker arm that could connect the ligase to the rest of the NHEJ complex. Ligase IV interacts with the extended a-helix of XRCC4 via a domain in the C terminus that contains two BRCT domains (Grawunder et al., 1998; Sibanda et al., 2001) . The XRCC4 protein exists under most conditions as a dimer and can form tetramers by interaction of two dimers via the region in the a-helix that also binds ligase IV . Although the function of XRCC4 tetramerization is not clear, this interaction might strengthen interactions between two NHEJ complexes on juxtaposed DNA ends.
Interaction between Ku70/80 and the DNA ligase IV/ XRCC4 complex is important for efficient NHEJ (Nick McElhinny et al., 2000) . Interactions of both the ligase component and the XRCC4 polypeptide with the Ku heterodimer have been described, which may all be necessary for efficient DNA end ligation (Chen et al., 2000; Hsu et al., 2002; Drouet et al., 2005; Mari et al., 2006; Costantini et al., 2007) . DNA-PK CS provides even additional stability to NHEJ complexes through interactions with XRCC4, although the ligase complex does not absolutely require the catalytic subunit for accumulation at DSBs. XLF/Cernunnos is the most recently identified NHEJ factor. The gene was cloned independently from immunodeficient patients that showed radio sensitivity (Buck et al., 2006) and by a yeast 2-hybrid screen for proteins that interact with XRCC4 (Ahnesorg et al., 2006) . It stimulates NHEJ, which appears to be mainly important for noncomplementary DNA ends, but does not seem to be an absolute requirement for the majority of DSBs (Gu et al., 2007; Tsai et al., 2007; Wu et al., 2007) .
Processing factors for NHEJ
The core NHEJ factors described above are sufficient to join compatible DNA ends that have a 5 0 phosphate and a 3 0 hydroxyl. However, most DSB inducing agents, such as ionizing radiation, create a large variety of DNA ends that need processing before they can be ligated (Nikjoo et al., 1998) . For this purpose, mammals have a large toolbox of enzymes to cope with all these damages.
Damaged DNA termini often require removal of one or a few damaged bases from the end before ligation can proceed. The Artemis nuclease was discovered as the gene that is mutated in the majority of radiosensitive T À B À severe combined immunodeficiency (SCID) patients (Moshous et al., 2001) . Its function in V(D)J recombination is opening of the coding end DNA hairpin structures that are formed by RAG1/2 cleavage at Recombination Signal Sequences (Ma et al., 2002; Pannicke et al., 2004; Poinsignon et al., 2004) . Artemis needs DNA-PK for its activity and DNA-PK phosphorylates Artemis, suggesting that Artemis phosphorylation by DNA-PK might be important . However, mutation of all phosphorylation sites in the Artemis gene did not result in diminished activity, whereas DNA-PK autophosphorylation was shown to be required for Artemis activation (Goodarzi et al., 2006) . Although the types of lesions that need Artemis mediated processing have not yet been identified, it is clear that a subset of 15-20% of ionizing radiation-induced DSBs remain unrepaired for several days in Artemis deficient cells (Riballo et al., 2004; Wang et al., 2005; Darroudi et al., 2007) .
Another feature of many DSBs is non-complementarity because of damaged or missing bases. Therefore, DNA ends often require synthesis of a limited number of nucleotides as part of the NHEJ process. Although short single-stranded gaps may be filled in by many different DNA polymerases, addition of nucleotides to a DSB is probably restricted to the Y-type DNA polymerases polm and poll, which have partially overlapping specificities (Lee et al., 2004; Nick McElhinny et al., 2005; Capp et al., 2006 Capp et al., , 2007 . To permit both DNA polymerization and ligation, a 3 0 -OH and a 5 0 -phosphate need to be present at the DNA ends. Polynucleotide kinase is recruited to DNA ends by interaction with XRCC4 and provides the activity to both remove 3 0 -phosphates and add 5 0 -phosphates (Koch et al., 2004) .
Other accessory factors for NHEJ
Several other factors have been found to be required for repair of the same subset of DSBs that require Artemis (Riballo et al., 2004) . These include the MRE11/ RAD50/NBS1 (MRN) complex, MDC1, 53BP1 and the ATM protein kinase, which were previously found to be involved in DNA damage-induced cell cycle checkpoints and apoptosis (Lavin and Kozlov, 2007 ). An important clue for the MRN function in DSB repair may come from the peculiar structure of this protein complex. The RAD50 component of this complex has two very long, flexible coiled-coil arms that contain a Zinc hook at the tip (Hopfner et al., 2002) . In the presence of Zn 2 þ , this structure forms a bridge between two RAD50 arms, suggesting that the MRN complex may be involved in keeping two DNA ends in close proximity. Juxtaposition of DNA ends through MRN interactions has indeed been observed using purified proteins and Scanning Force Microscopy (de Jager et al., 2001; Moreno-Herrero et al., 2005) and this protein complex has been found to accumulate in large nuclear foci within minutes after DSB formation (Maser et al., 1997) . Although the function of these foci is not clear, several mutants that do support focus formation show DSB repair defects. They have been hypothesized to support accumulation of a high local concentration of repair proteins. However, in light of the specific structure of the MRN complex, one could also imagine, that MRN (probably together with other proteins) forms a microenvironment that holds together the two DNA ends. Such a 'sticky ball' would allow some degree of freedom for movement of DNA ends and access of (NHEJ) proteins within this structure (Figure 2a) .
MRN foci formation requires several other factors, including the MDC1 and 53BP1 proteins and phosphorylation of histone variant H2AX (Celeste et al., 2003; Ward et al., 2003; Xu and Stern, 2003; Lee et al., 2005) . As the ATM protein kinase is the major H2AX kinase after induction of DSBs, the main function of ATM could be creation of a chromatin environment that facilitates MRN accumulation in nuclear foci. This notion is supported by the observation, that cells deficient in all these repair factors have similar repair defects, most notably increased levels of residual DSBs after ionizing radiation and chromosomal instability (Ward et al., 2003; Franco et al., 2006; Lou et al., 2006; Lavin and Kozlov, 2007) .
However, it is not directly clear why these foci forming factors would be required for the same subset of DSBs that require processing by Artemis. They might all be involved in activating the Artemis activity, but all biochemical evidence shows that Artemis nuclease depends only on DNA-PK activity. Therefore, we would like to propose a different explanation for this phenomenon ( Figure 2b ). As described above, Ku70/80 and DNA-PK CS are in dynamic equilibrium between the DNA bound and free states. This implies that DNA ends loose their NHEJ complexes every few minutes. In principle, free DNA ends might loose juxtaposition unless some other structure keeps them together. We propose, that the 'sticky ball' of MRN complexes may carry out this function. Obviously, the chance to loose the other end of the DSB in the absence of the 'sticky ball' is higher for DNA ends that require more time for joining, for example, because of processing. Therefore, the subset of DSBs that requires Artemis would largely coincide with DSBs that need the 'sticky ball' to keep them juxtaposed. After DSB formation, the non-homologous end-joining (NHEJ) proteins and MRN accumulate more or less independently on the DNA. When only NHEJ proteins hold the ends together, the DNA ends can either be joined directly or the NHEJ proteins can dissociate from the complex, which can lead to loss of juxtaposition of the ends. However, when the 'sticky ball' of MRN is present, the ends will be held in close proximity, even when the NHEJ complex falls apart. Although each protein molecule in the 'sticky ball' can exchange rapidly with protein molecules in solution, the structure stays intact. It is not yet clear which step in this process should happen first, but we expect that the order of events is not fixed.
Alternative end-joining pathways
Although the major end-joining pathway relies on DNA-PK and ligase IV, backup pathways can support a low level of end joining. This backup system relies mainly on patches of a few base pairs of (micro)homology, that may assist in alignment of the ends (Kabotyanski et al., 1998; Verkaik et al., 2002) . Although microhomology-mediated end-joining is not very efficient for V(D)J recombination and repair of blunt DSBs (van Heemst et al., 2004) , this backup pathway can mediate Ig heavy chain class switch recombination in B cells rather efficiently (Yan et al., 2007) . However, this microhomology driven backup system appears to be quite error-prone, as chromosomal translocations have frequently been found to contain microhomologies at the junctions. The existence of backup end-joining pathways may explain why chromosomal translocations have been found regularly in cells with defects in NHEJ components, although this process obviously requires joining of DNA ends (Iliakis et al., 2004; Burma et al., 2006) .
Intersection of NHEJ with other cellular processes
The DNA damage response includes not only repair, but also regulation of cell-cycle progression and apoptosis. These processes are intimately connected and several proteins have functions at multiple levels. For example, the Ku70 protein is not only involved in NHEJ as part of the Ku70/80 heterodimer, but it also influences apoptosis by interaction with the proapoptotic Bax protein (Sawada et al., 2003) . On the other hand, the cell-cycle checkpoint protein kinase ATM is most probably also directly involved in repair of a subset of DSBs (Riballo et al., 2004) , showing that many proteins function in more than one genetic pathway.
Furthermore, most NHEJ proteins have been found to interact with telomeres. Obviously, these chromosome ends are DNA ends that should not be joined to another DNA end. However, the Ku70/80 heterodimer, DNA-PK CS and the MRN complex have been found to preferentially localize to these structures (Bailey et al., 1999; Slijepcevic, 2006) . These interactions do not promote end-joining and even seem to prevent end-to-end fusion of chromosomes.
NHEJ and developmental defects in mice and men NHEJ defects in mammals result in absence of B and T cells and give rise to SCID. Both cellular and humoral immunity are affected and these patients are clinically characterized by opportunistic infections, protracted diarrhea and failure to thrive, which becomes apparent during the first months of life (See also de Villartay et al. in this issue). Mutations in the RAG1 and RAG2 genes account for B70% of all T À B À SCID patients (Schwarz et al., 1996) . The majority of the remaining patients show hypersensitivity to ionizing radiation, because the V(D)J recombination deficiency results from a defect in NHEJ. The majority of these patients have mutations in Artemis (Moshous et al., 2001; Li et al., 2002; Kobayashi et al., 2003; Noordzij et al., 2003) . The clinical phenotype of RAG1, RAG2 and Artemis-deficient patients is similar and can be mimicked in mice (Table 1) . A partial V(D)J recombination defect caused by hypomorphic mutations in RAG1, RAG2 or Artemis leads to the Omenn's syndrome, which is characterized by prominent generalized papular skin eruption, eosinophilia, hyper IgE, circulating oligoclonal T-cells in addition to the failure to thrive and opportunistic infections (Villa et al., 1998; Ege et al., 2005) . Other cases of hypomorphic mutations in Artemis have been associated with partial T-and B-cell immunodeficiency with the development of aggressive EBV-associated B-cell lymphomas (Moshous et al., 2003) .
Mutations in the DNA ligase IV gene are also associated with immunodeficiencies. The clinical spectrum of these patients is quite diverse, varying from radiosensitive leukemia, via the LIG4 syndrome (that is characterized by immunodeficiency, microcephaly and growth retardation) to radiosensitive SCID (Riballo et al., 1999; O'Driscoll et al., 2001; van der Burg et al., 2006) . As DNA ligase IV knockout mice are embryonic lethal, the LIG4 mutations found in patients are most probably hypomorphic. The different types of mutations might explain the variation in clinical phenotype, although differences in other genes could also contribute to this variability. Finally, mutations in the ligaseassociated XLF/Cernunnos gene have been found in patients with growth retardation, microcephaly and immunodeficiency due to profound T and B-cell lymphocytopenia (Buck et al., 2006) . Other NHEJ components have not been found mutated in human SCID patients yet, but based on the phenotype of the XRCC4, Ku70, Ku80 and DNA-PK CS knockout mice, mutations in these genes are also expected to result clinically in SCID.
Although most defects described above result in T À B À SCID, more careful characterization of these patients revealed interesting differences. First, the NHEJ defect is characterized by studying DSB repair kinetics, using gH2AX foci counting in primary fibroblasts after irradiation. For example, DNA ligase IV-deficient fibroblasts display slow DSB repair (van der Burg et al., 2006) , whereas Artemis-deficient cells show normal fast initial DSB repair, with 15-20% of DSB that are not repaired at all (Riballo et al., 2004; Wang et al., 2005; Darroudi et al., 2007) . The precise analysis of V(D)J recombination products is also very informative. V(D)J recombination substrates can be transfected into patient cells (primary fibroblasts) or residual junctions from bone marrow precursor B-cells can be amplified (Table 2) (Verkaik et al., 2002; van der Burg et al., 2006 van der Burg et al., , 2007 . Artemis deficiency causes normal signal joint formation, but a strong reduction in the numbers of coding joints, which are characterized by long stretches of P-nucleotides due to aberrant hairpin opening (Rooney et al., 2003; van der Burg et al., 2007) . The junction characteristics are therefore indicative for the affected V(D)J recombination component and the integration of all results facilitates recognition of new genetic defects.
Finally, identification of novel NHEJ factors has been shown by de Villartay and co-workers (Moshous et al., 2001; Buck et al., 2006) . They developed approaches to clone genes involved in NHEJ by complementation of radiosensitive fibroblasts using a cDNA expression library approach and selection schemes that make use of the NHEJ defect. The combination of these approaches has been very successful for identification of mutations in patients as well as gaining knowledge about the mechanism of NHEJ.
DNA repair defects can also have impact on neuronal development. NHEJ is critical for differentiating cells to prevent apoptosis of the post-mitotic neurons (Lee and McKinnon, 2007) . This is particularly clear in DNA ligase IV and XRCC4-deficient mice (Frank et al., 1998; Gao et al., 1998b) , but Ku70 or Ku80 deficiency shows similar defects to a lesser extent (Nussenzweig et al., 1996; Gu et al., 1997) . The neuropathy in patients with the LIG4 syndrome and XLF/Cernunnos deficiency is confined to characteristic facial features and microcephaly, suggesting that these mutations do not cause a complete NHEJ deficiency.
Mutations in NHEJ accessory factors are more difficult to interpret. Ataxia telangiectasia (AT) is characterized by loss of Purkinje cells, which results in a progressive ataxia (Digweed et al., 1999; Chun and Gatti, 2004; McKinnon, 2004) . It is caused by mutations in the ATM protein kinase, which functions not only in NHEJ, but also in maintaining cell-cycle checkpoints and apoptotic responses. Nijmegen Breakage syndrome (NBS) shares several cellular characteristics with AT, although these patients do not show ataxia. Instead they display microcephaly and a mild mental retardation. Again, it is not clear whether the NHEJ defect adds to the brain phenotype of these patients. Finally, AT like disorder results from hypomorphic mutations in MRE11 and is very similar to AT (Taylor et al., 2004) .
NHEJ and carcinogenesis
Most tumors show chromosomal instability, which may add to their malignant phenotype. However, most mouse models with deficiencies in NHEJ genes are not extremely cancer prone, although chromosomal instability at the chromosomal level is severely increased. Apparently, other cellular safeguards ('gate keepers') prevent malignant transformation. Indeed, combination of the NHEJ defect with p53 deficiency leads to extremely fast development of B-cell tumors in mice . Even reduced NHEJ capacity can facilitate malignant transformation in a checkpoint-deficient genetic background such as DNA ligase IV heterozygosity in ink4a/arf À/À mice (Sharpless et al., 2001 ). The dependence on various mechanisms to control tumor development is not equal in all cell types. For example, the ligase IV deficiency in a p53 deficient background results in lymphoid tumors (Frank et al., 2000) , while ligase IV heterozygosity in the ink4a/arf deficient mice increases the incidence of soft-tissue sarcomas (Sharpless et al., 2001) . The effect on genome stability varies also between different cell types, for example heterozygosity in the Ku80, ligase IV or XRCC4 Non-homologous end-joining DC van Gent and M van der Burg genes increased genomic instability in fibroblasts, but not in cultured developing lymphocytes (Karanjawala et al., 1999) .
In contrast to NHEJ defects, mutations of the ATM and NBS1 genes increase tumorigenesis, even in the absence of additional mutations. The repair defect in ATM or NBS1 deficient cells resembles Artemis deficiency very closely, but tumorigenesis is much more pronounced in AT or NBS patients. This can most probably be explained by a combination of defects: both genes are not only involved in NHEJ, but also in cell-cycle checkpoints and DSB-induced apoptosis (Deckbar et al., 2007; Lavin and Kozlov, 2007) . Furthermore, aberrant rejoining appears to be much more frequent in AT or NBS cells than in Artemis deficient cells (Darroudi et al., 2007) , which can be explained by a defect in maintaining juxtaposition of DNA ends, rather than an inability to process the lesion in preparation for joining.
In conclusion, decreased NHEJ capacity increases chromosomal instability, which is a hallmark of many tumors. However, very high levels of tumorigenesis require also defects in cell-cycle checkpoints or apoptosis, which would otherwise prevent proliferation of cells with DNA damage. A more profound knowledge of the interactions between these 'care taker' and 'gate keeper' functions will help in understanding the carcinogenic process and applying this knowledge to develop anticancer treatments.
